BCAA 2:1:1
Affiliate link: we may earn a commission at no extra cost to you. Disclosures
BCAA 2:1:1. Leucine:Isoleucine:Valine for muscle.
How it works. Leucine-rich blend stimulates mTOR.
What the research supports. 1 graded claims. Strongest: Reduces DOMS (moderate).
How much to take. Typical dose: 5–10 g.
Side effects and interactions. 1 medication interaction listed. No serious side effects listed at normal doses.
Stacking. Pairs well with Creatine monohydrate, Whey or EAAs.
Common forms. Available as Free-form crystalline powder, Capsules or tablets, Pre-mixed recovery or hydration beverages, Time-release formulations.
Key studies. 8 studies cited. The strongest are listed with links to PubMed.
Community. Experiences from people who have tried BCAA 2:1:1. Anecdotes are not medical advice.
BCAA 2:1:1. Leucine:Isoleucine:Valine for muscle.
What it is
Leucine:Isoleucine:Valine for muscle.
Food sources
Goals
How it works
Leucine-rich blend stimulates mTOR.
Pathways
- Leucine-rich blend stimulates mTOR
Effects
- ↓DOMS decreases
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
As an Amazon Associate I earn from qualifying purchases. Look for USP, NSF or Informed Sport seals before you buy.
Side effects & interactions
Common side effects
- Well tolerated
Medication interactions
Always disclose BCAA 2:1:1 use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- Creatine monohydrateFoundational support for strength, power, and lean mass.
- Whey or EAAsProvides amino acid substrate for muscle protein synthesis.
Common forms
- Free-form crystalline powder
- Capsules or tablets
- Pre-mixed recovery or hydration beverages
- Time-release formulations
Key studies
8 studies cited in total.
Opens current human and preclinical literature matching BCAA 2:1:1 and "Reduces DOMS". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching BCAA 2:1:1 and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching BCAA 2:1:1 and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.
Discussion
Loading discussion…